Have we made progress in taking care of adolescents and young adults with cancer? Results of a European multi-professional survey.


Journal

Tumori
ISSN: 2038-2529
Titre abrégé: Tumori
Pays: United States
ID NLM: 0111356

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 6 12 2023
pubmed: 24 7 2023
entrez: 24 7 2023
Statut: ppublish

Résumé

It is well documented that traditional health care models do not meet the specific needs of Adolescents and Young Adults (AYA) cancer patients. We explore a map of the development of age-specific AYA cancer care across Europe, from the perspective of healthcare professionals with an interest in AYA care, in order to understand the specific challenges and map progress over time. An on-line survey was developed by international professional cancer organisations. We had 377 respondents from 60 countries. The majority of respondents were physicians 298 (79%), a minority of survey respondents (39, 10.4%) work exclusively with AYA patients, most respondents declared substantial and routine clinical service collaborations to provide care and treatment to AYA with cancer. Policy for the multidisciplinary management of AYA cancer patients commonly appears in Europe now, and was reported by 234 (78.52%) respondents. Specific professional training for AYA cancer care is not uniformly available. There is considerable opportunity for many organisations to work together in raising the profile of AYA cancer related issues, in providing education and in encouraging research and collaboration.

Sections du résumé

BACKGROUND UNASSIGNED
It is well documented that traditional health care models do not meet the specific needs of Adolescents and Young Adults (AYA) cancer patients.
METHODS UNASSIGNED
We explore a map of the development of age-specific AYA cancer care across Europe, from the perspective of healthcare professionals with an interest in AYA care, in order to understand the specific challenges and map progress over time. An on-line survey was developed by international professional cancer organisations.
RESULTS UNASSIGNED
We had 377 respondents from 60 countries. The majority of respondents were physicians 298 (79%), a minority of survey respondents (39, 10.4%) work exclusively with AYA patients, most respondents declared substantial and routine clinical service collaborations to provide care and treatment to AYA with cancer. Policy for the multidisciplinary management of AYA cancer patients commonly appears in Europe now, and was reported by 234 (78.52%) respondents. Specific professional training for AYA cancer care is not uniformly available.
CONCLUSION UNASSIGNED
There is considerable opportunity for many organisations to work together in raising the profile of AYA cancer related issues, in providing education and in encouraging research and collaboration.

Identifiants

pubmed: 37486101
doi: 10.1177/03008916231183477
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

546-554

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Prof Dan Stark has received grant funding for AYA cancer research from the Teenage Cancer Trust, UK NIHR, UK ESRC and EU Horizon programmes.The other authors declare that there is no conflict of interest.

Auteurs

Ivana Bozovic Spasojevic (I)

Medical Oncology Department, Institute for Oncology and Radiology of Serbia, Belgrade, Republic of Serbia.

Andrea Ferrari (A)

Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

Johan De Munter (J)

University Hospital Ghent Cancer Center, Ghent, Belgium.
European Oncology Nursing Society.

Ashley Gamble (A)

Children's Cancer and Leukaemia Group, Leicester, UK.

Assia Konsoulova-Kirova (A)

National Oncology Hospital, Sofia, Bulgaria.

Katie Rizvi (K)

Youth Cancer Europe, Cluj-Napoca, Romania.

Carina Schneider (C)

Childhood Cancer International Europe, Vienna, Austria.

Marie Balsat (M)

Department of Hematology, Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France.

Anna Castleton (A)

The Christie Hospital, Manchester, UK.

Leila Gofti-Laroche (L)

Department of Public Health-University of Grenoble Alps, AYA Unit-Centre Hospitalier Universitaire de Grenoble Alpes, Grenoble, France.

Anita Kienesberger (A)

Childhood Cancer International Europe, Vienna, Austria.

Beate Timmermann (B)

University Medicine Essen, Clinic for Particle Therapy, West German Proton Therapy Center Essen, Essen, Germany.

Josef Vormoor (J)

Princess Máxima Center for Pediatric Oncology and University Medical Center Utrecht, Netherlands.

Emmanouil Saloustros (E)

Department of Oncology, University Hospital of Larissa, Larissa, Greece.

Daniel P Stark (DP)

Leeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH